How are CYP2C19 and skin aging related?

The provided context contains no information linking CYP2C19 to skin aging. CYP2C19 is a drug-metabolizing enzyme (e.g., for proton pump inhibitors, clopidogrel) and is not typically associated with skin aging. Skin aging is primarily driven by UV exposure, lifestyle factors (diet, smoking), and other genetic variants (e.g., MC1R, collagen genes). There is no robust evidence from the context database supporting a direct relationship between CYP2C19 variants and skin aging. Even if a DNA test shows a CYP2C19 variant, its effect on skin aging is likely negligible. The evidence is rated as 'unclear'. For specific skin concerns, consult a dermatologist.